Status: Recruiting
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
To learn if SAR445877 in combination with FOLFOX6 and bevacizumab can be safely given to patients with advanced MSS CRC.
Participants needed: 41
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 1, 2026Locations: 1
Eligibility criteria
Ability to understand and willingness to sign informed consent form prior to ini... [+22]
Pregnant or breastfeeding. [+20]